Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Potier

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
La Revue Du Praticien|June 23, 2021
["Cardiovascular assessment in diabetics: should silent ischemia be screened?"]Louis Potier
La Revue Du Praticien|October 23, 2025
[Should diabetic patients be screened for silent myocardial ischemia ?]Louis Potier
La Revue Du Praticien|January 12, 2016
[When and why start insulin in type 2 diabetes?]Louis Potier
Circulation|January 8, 2019
Letter by Potier and Roussel Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes"Louis Potier, Ronan Roussel
Lancet (London, England)|April 14, 2017
Cutaneous adverse events related to FreeStyle Libre deviceNesrine Brahimi, Louis Potier, Kamel Mohammedi
JAMA|March 25, 2015
Coronary artery disease screening using coronary computed tomography angiographyLouis Potier, Nadia Matallah, Kamel Mohammedi
The New England Journal of Medicine|October 29, 2015
A Paclitaxel-Coated Balloon for Femoropopliteal Artery DiseaseLouis Potier, Salma El Batti, Kamel Mohammedi
Cardiovascular Diabetology|May 14, 2021
SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesisLouis Potier, Kamel Mohammedi, Gilberto Velho, et al.
Cells|December 23, 2022
Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 DiabetesKamel Mohammedi, Michel Marre, Samy Hadjadj, et al.
Diabetes Care|April 16, 2009
Automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patientsCécile Clairotte, Sylvie Retout, Louis Potier, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
La Revue Du Praticien|June 23, 2021
["Cardiovascular assessment in diabetics: should silent ischemia be screened?"]Louis Potier
La Revue Du Praticien|October 23, 2025
[Should diabetic patients be screened for silent myocardial ischemia ?]Louis Potier
La Revue Du Praticien|January 12, 2016
[When and why start insulin in type 2 diabetes?]Louis Potier
Circulation|January 8, 2019
Letter by Potier and Roussel Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes"Louis Potier, Ronan Roussel
Lancet (London, England)|April 14, 2017
Cutaneous adverse events related to FreeStyle Libre deviceNesrine Brahimi, Louis Potier, Kamel Mohammedi
JAMA|March 25, 2015
Coronary artery disease screening using coronary computed tomography angiographyLouis Potier, Nadia Matallah, Kamel Mohammedi
The New England Journal of Medicine|October 29, 2015
A Paclitaxel-Coated Balloon for Femoropopliteal Artery DiseaseLouis Potier, Salma El Batti, Kamel Mohammedi
Cardiovascular Diabetology|May 14, 2021
SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesisLouis Potier, Kamel Mohammedi, Gilberto Velho, et al.
Cells|December 23, 2022
Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 DiabetesKamel Mohammedi, Michel Marre, Samy Hadjadj, et al.
Diabetes Care|April 16, 2009
Automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patientsCécile Clairotte, Sylvie Retout, Louis Potier, et al.
Pageof 10